Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-08-31
2009-02-24
Saeed, Kamal A (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S178000
Reexamination Certificate
active
07495021
ABSTRACT:
The invention concerns the use as cdc25 phosphatase inhibitors, in particular cdc25-C phosphatase, and CD45 phosphatase, of compounds of general formula (I), wherein: W represents O or S. In accordance with the invention, the compounds of general formula (I) can in particular be used for preparing a medicine for cancer treatment.
REFERENCES:
patent: 5523430 (1996-06-01), Patel et al.
patent: 7279467 (2007-10-01), Galcera Contour et al.
patent: 7335674 (2008-02-01), Galcera Contour et al.
patent: 2006/0135573 (2006-06-01), Galcera Contour et al.
patent: 2006/0281736 (2006-12-01), Prevost et al.
patent: 2007/0255063 (2007-11-01), Galcera Contour et al.
patent: 2007/0293487 (2007-12-01), Galcera Contour et al.
patent: 1 534 275 (1978-11-01), None
patent: 97/30053 (1997-02-01), None
patent: 01/34203 (2001-05-01), None
patent: 01/45680 (2001-06-01), None
patent: WO 02/096348 (2002-12-01), None
patent: 03/050098 (2003-06-01), None
patent: 03/055868 (2003-07-01), None
patent: 2005/000843 (2005-01-01), None
patent: 2005/000852 (2005-01-01), None
patent: 2006/051202 (2006-05-01), None
patent: 2006/067311 (2006-06-01), None
Ryu et al., “Synthesis and Antifungal Activities of 5/6-arylamino-4,7-Dioxobenzothiazoles”, Bio-Organic and Medicinal Chemistry Letters, vol. 10, No. 14, pp. 1589-1591, (Jul. 17, 2000).
Ryu et al., “5-Arylamino-2-methyl-4,7 Dioxobenzothiazoles as Inhibitors of Cyclin-Dependent Kinase 4 and Cytocoxic Agents”, Bio-Organic and Medicinal Chemistry Letters, vol. 10, No. 5, pp. 461-464, (Mar. 5, 2000).
Lyon et al., “Synthesis and Structure Verification of an Analogue of Kuanoniamine A,” J.Chem. Soc. Perkin Transactions 1: Organic and BioOrganic Chemistry, vol. 4; pp. 437-442 (1999).
Kristjansdottir et al., “Cdc25 Phosphatases and Cancer”, Chemistry and Biology, vol. 11, pp. 1043-1051 (Aug. 2004).
Ryu et al., “Modulation of NAD(P)H: Quinone Qxidoreductase (NQO1) Activity Mediated by 5-arylamino-2-methyl-4-7- Dioxobenzothiazoles and their Cytotoxic Potential”, Archives of Pharmacal Research, vol. 23, issue 6, pp. 554-558 (2000).
Eckstien, J.W., “Cdc25 as a Potential Target of Anticancer Agents” Investigational New Drugs, vol. 18, pp. 149-156, Figure 3a (2000).
McCain, D.F. et al., Suramin Derivatives as Inhibitors and Activators of Protein-Tyrosine Phosphates, Jpurnal of Biological Chemistry, vol. 129, No. 15, pp. 14713-14725, Figures 2-6 (Jan. 2004).
Talaga, P. et al., “Synthesis of Boc-Cys—Ala—OMe and its Stereoselective Addiction to α-Methylene-γ-Butrolactones”, Tetrahedron, vol. 45, No. 16, pp. 5029-5038 (1989).
Zhu, X. et al. “Synthesis of S-Linked Glycopeptides in Aqueous Solution”. J. Org. Chem., vol. 68, No. 14, pp. 5641-5651, XP002326455, Schema 1 (2003).
Golub et al., “Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring”, Science, vol. 286, pp. 531-537 (1999).
Hortobagyl, G. “Treatment of Breast Cancer”, N. Engl., J. Med, 339, pp. 974-984 (1998).
Preliminary Amendment Filed Jun. 18, 2007 in Co-pending U.S. Appl. No. 11/722,075.
International Preliminary Report on Patentability (Form PCT/IPEA/409) in International Application No. PCT/FR2005/002763 (WO 06/051202).
International Preliminary Report on Patentability (Form PCT/IPEA/409) in International Application No. PCT/FR2005/003161 (WO 06/067311).
International Preliminary Report on Patentability (Form PCT/IPEA/409) in International Application No. PCT/FR02/04544 (WO 03/055868).
International Preliminary Report on Patentability (Form PCT/IPEA/409) in International Application No. PCT/FR2004/001578 (WO 05/000843).
International Preliminary Report on Patentability (Form PCT/IPEA/409) in International Application No. PCT/FR2004/001586 (WO 05/000852).
Brezak Pannetier Marie-Christine
Galcera Contour Marie-Odile
Lavergne Olivier
Prevost Grégoire
Bianchi Kristin
Hunton & Williams LLP
Saeed Kamal A
Societe de Conseils de Recherches et d'Applications Scientifique
LandOfFree
Benzothiazole- and benzooxazole-4,7-dione, derivatives and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzothiazole- and benzooxazole-4,7-dione, derivatives and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzothiazole- and benzooxazole-4,7-dione, derivatives and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4122790